Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
-$3.22B
(-5.6%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
+$208M |
| 2 |
Norfolk Southern
NSC
|
+$145M |
| 3 |
Insmed
INSM
|
+$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$136M |
| 5 |
Soleno Therapeutics
SLNO
|
+$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$355M |
| 2 |
Royalty Pharma
RPRX
|
+$334M |
| 3 |
McDonald's
MCD
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$188M |
| 5 |
HES
Hess
HES
|
+$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
776
Schlumberger
SLB
$52.7B
| $1.46M | ﹤0.01% |
35,013
-255,811
| -88% | -$10.7M |
|
777
Talos Energy
TALO
$1.66B
| $1.46M | ﹤0.01% |
150,000
-662,348
| -82% | -$6.44M |
|
778
AN2 Therapeutics
ANTX
$31.4M
| $1.36M | ﹤0.01% |
1,000,000
+687,385
| +220% | +$935K |
|
779
Shoals Technologies Group
SHLS
$1.13B
| $1.33M | ﹤0.01% |
400,000
| – | – |
|
780
Moog
MOG.A
$6.19B
| $1.31M | ﹤0.01% |
7,553
| – | – |
|
781
Sutro Biopharma
STRO
$83.5M
| $1.3M | ﹤0.01% |
2,000,000
| – | – |
|
782
Alignment Healthcare
ALHC
$3.26B
| $1.29M | ﹤0.01% |
69,497
+35,000
| +101% | +$652K |
|
783
Liberty Energy
LBRT
$1.7B
| $1.27M | ﹤0.01% |
80,000
| – | – |
|
784
Albemarle
ALB
$8.71B
| $1.24M | ﹤0.01% |
17,279
-42,500
| -71% | -$3.06M |
|
785
Werner Enterprises
WERN
$1.64B
| $1.19M | ﹤0.01% |
40,545
| – | – |
|
786
Invesco
IVZ
$9.9B
| $1.15M | ﹤0.01% |
+75,941
| New | +$1.15M |
|
|
CBIO
787
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $1.07M | ﹤0.01% |
50,912
| – | – |
|
788
Biomea Fusion
BMEA
$109M
| $1.07M | ﹤0.01% |
500,000
| – | – |
|
789
HealthEquity
HQY
$7.92B
| $1.06M | ﹤0.01% |
12,000
+4,000
| +50% | +$353K |
|
790
CNO Financial Group
CNO
$3.79B
| $1.04M | ﹤0.01% |
+25,000
| New | +$1.04M |
|
791
Surrozen
SRZN
$100M
| $1.03M | ﹤0.01% |
88,653
+24,000
| +37% | +$280K |
|
792
DexCom
DXCM
$29.9B
| $1.03M | ﹤0.01% |
15,121
-540,000
| -97% | -$36.9M |
|
|
IMA
793
ImageneBio, Inc. Common Stock
IMA
$101M
| $1.02M | ﹤0.01% |
66,667
| – | – |
|
794
Alexandria Real Estate Equities
ARE
$14.4B
| $981K | ﹤0.01% |
+10,600
| New | +$981K |
|
795
Applied Therapeutics
APLT
$64.8M
| $959K | ﹤0.01% |
1,961,629
| – | – |
|
796
AngioDynamics
ANGO
$443M
| $939K | ﹤0.01% |
+100,000
| New | +$939K |
|
797
Match Group
MTCH
$9.03B
| $908K | ﹤0.01% |
29,116
-5,500
| -16% | -$172K |
|
798
Carnival Corp
CCL
$42.1B
| $900K | ﹤0.01% |
46,084
-924,416
| -95% | -$18.1M |
|
799
Trinity Industries
TRN
$2.27B
| $841K | ﹤0.01% |
+29,978
| New | +$841K |
|
800
Lexeo Therapeutics
LXEO
$288M
| $826K | ﹤0.01% |
237,953
-1,971,662
| -89% | -$6.84M |
|